Cardiomyopathy, HypertrophicBlood PressureClot RetractionBlood CoagulationFibrinRisk FactorsFibrinolysisThrombelastographyTissue Plasminogen ActivatorThrombosisFibrinogenFactor XIIIaBlood Coagulation TestsUltrasonic TherapyHemostaticsFibrinolytic AgentsHemoglobin HPlasminogenHigh-Intensity Focused Ultrasound AblationPulmonary EmbolismHemostasisalpha-2-AntiplasminFibrinolysinFactor XIIIBlood Coagulation DisordersThrombinIntracranial EmbolismCerebral HemorrhageStreptokinaseThrombolytic TherapySubarachnoid HemorrhagePlatelet ActivationBlood PlateletsBloodPlasminogen ActivatorsHeparinRabbitsHemorrhageDogsDisease Models, AnimalTime FactorsFibrin Clot Lysis TimeRecombinant ProteinsStrokeSwineKineticsTreatment OutcomeFibrinogens, AbnormalCarboxypeptidase UNephelometry and TurbidimetryIntracranial ThrombosisFibrinopeptide BFibrin Fibrinogen Degradation ProductsThrombin TimeBatroxobinUrokinase-Type Plasminogen ActivatorAfibrinogenemiaMechanical ThrombolysisFibrinopeptide AFactor XIII DeficiencyWhole Blood Coagulation TimePlatelet Aggregation